Medicare Enrolled

Dr. Sandeep Mehta, M.D.

Urology Physician · Baytown, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
4201 GARTH RD STE 307, Baytown, TX 77521
8325566046
In practice since 2014 (11 years)
NPI: 1124447271 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mehta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mehta? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mehta

Dr. Sandeep Mehta is an urology physician in Baytown, TX, with 11 years in practice. Based on federal Medicare data, Dr. Mehta performed 238 Medicare services across 222 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mehta received a total of $4,064 from 31 pharmaceutical and/or device companies across 122 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mehta is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice▲ 238 Medicare services$ $4,064 industry payments

Medicare Practice Summary

Medicare Utilization ↗
238
Medicare services
Bottom 11% in TX for urology physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
222
Unique beneficiaries
$37
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~22 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Automated urinalysis76$2$2
Office visit, established patient (20-29 min)41$49$94
Office visit, established patient (30-39 min)35$66$132
Blood draw (venipuncture)31$8$8
Bladder ultrasound after voiding21$7$11
Initial hospital admission, high complexity18$139$440
New patient office visit (45-59 min)16$90$172
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,064
Total received (2019-2024)
Avg $677/year across 6 years
Top 43% in TX for urology physician
31
Companies
122
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,911 (96.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$154 (3.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$220
2023
$366
2022
$1,213
2021
$698
2020
$455
2019
$1,111

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
NeoTract Inc.
$1,148
Astellas Pharma US Inc
$355
Antares Pharma, Inc.
$287
PROCEPT BioRobotics Corporation
$247
Endo Pharmaceuticals Inc.
$241
Boston Scientific Corporation
$239
PFIZER INC.
$203
Teleflex LLC
$172
AstraZeneca Pharmaceuticals LP
$124
E.R. Squibb & Sons, L.L.C.
$122
Merck Sharp & Dohme LLC
$120
Progenics Pharmaceuticals, Inc.
$108
AbbVie Inc.
$87
Hollister Incorporated
$78
Ambu Inc.
$68
Myriad Genetic Laboratories, Inc.
$54
UROVANT SCIENCES INC
$48
Merck Sharp & Dohme Corporation
$43
Alnylam Pharmaceuticals Inc.
$43
Axonics, Inc.
$32
Bayer HealthCare Pharmaceuticals Inc.
$32
UroGen Pharma, Inc.
$27
Medtronic, Inc.
$26
Tolmar, Inc.
$25
Sumitomo Pharma America, Inc.
$23
Tempus AI, Inc
$23
TOLMAR Pharmaceuticals, Inc.
$23
BioTissue Holdings, Inc.
$21
Coloplast Corp
$19
BOSTON SCIENTIFIC CORPORATION
$16
Abbott Laboratories
$11
Top 3 companies account for 44.1% of total payments
Associated products mentioned in payments ›
AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Axonics · BRAC CDx · EDEX · ELIGARD · GEMTESA · GIVLAARI · INTERSTIM · JELMYTO · KEYTRUDA · LUPRON DEPOT · MYRBETRIQ · MitraClip System · Myrbetriq · NEOX · NOCDURNA · Nubeqa · OPDIVO · PREMARIN · PROLARIS · PYLARIFY · REZUM · Rezum Generator · Solyx SIS System · SpaceOAR VUE System - 10mL · SpeediCath · TOVIAZ · UROLIFT · UroLift · UroLift System · VaPro · VaPro Plus Pocket · XIAFLEX · XT CDX · XTANDI · XYOSTED · Xtandi
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $1,708 per 100 Medicare services performed
Looking for a urology physician in Baytown?
Compare urology physicians in the Baytown area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology Physicians within 10 mi
42
Per 100K population
0.9
County median income
$73,104
Nearest hospital
HOUSTON METHODIST BAYTOWN HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Mehta is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Mehta experienced with automated urinalysis?
Based on Medicare claims data, Dr. Mehta performed 76 automated urinalysis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mehta receive payments from pharmaceutical companies?
Yes. Dr. Mehta received a total of $4,064 from 31 companies across 122 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mehta's costs compare to other urology physicians in Baytown?
Dr. Mehta's average Medicare payment per service is $37. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mehta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →